⌘K

Login Start Free

Home/Filings/4/A/0001127602-24-011128

4/A//SEC Filing

FOSTER JAMES C 4/A

Accession 0001127602-24-011128

CIK 0001100682other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 6:58 PM ET

Size

10.7 KB

Accession

0001127602-24-011128

Insider Transaction Report

Form 4/AAmended

Period: 2024-01-29

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL

DirectorPresident and CEO

Transactions

Award
Common Stock
2024-01-29+23,741→ 238,858 total
Tax Payment
Common Stock
2024-01-29$220.28/sh−10,540$2,321,751→ 228,318 total

Holdings

Common Stock
(indirect: 2023 GRAT)
20,000
Common Stock
(indirect: By Spouse)
10,000
Common Stock
(indirect: By Trust)
2,250
Common Stock
(indirect: 2022 GRAT)
7,580
Common Stock
(indirect: By Trust)
340
Common Stock
(indirect: By Trust)
750

Footnotes (1)

[F1]Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021.

Documents

1 file

4
form4a.xml
PRIMARY DOCUMENT

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1

filerCIK 0001141722

Filing Metadata

Form type: 4/A
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 6:58 PM ET
Size: 10.7 KB

View on SEC.gov